CLTRN and head and neck squamous cell carcinoma: These findings provide valuable insights into the mechanisms underlying radioresistance in HNSCC and highlight the therapeutic potential of targeting the G9a- TMEM27-ferroptosis axis to improve radiotherapy outcomes.